複雑疾患における遺伝的変異と臨床症状の関連研究(Background genetic variants influence clinical features in complex disorders)

ad

2025-10-07 ペンシルベニア州立大学(PennState)

ペンシルベニア州立大学主導の国際研究チームは、疾患関連の主要遺伝変異が人によって異なる臨床症状を示す仕組みを解明した。研究では、発達遅滞や自閉症に関連する染色体16p12.1欠失を持つ442人を解析し、個人ごとに異なる「二次的遺伝変異(背景変異)」が症状の重症度や特徴を左右することを発見。例えば、短いDNA反復配列の拡張を持つ子どもは神経系症状を併発する傾向が強かった。また、健常者主体のバイオバンクと臨床群では、主要変異と症状の関連が異なることも確認。研究は、複雑疾患の個別化医療に向けた基盤となる。

複雑疾患における遺伝的変異と臨床症状の関連研究(Background genetic variants influence clinical features in complex disorders)
Credit: Corrine Smolen/Girirajan Laboratory / Penn State. Creative Commons

<関連情報>

遺伝子修飾因子と確認は複雑な疾患の多様な表現度を駆動する Genetic modifiers and ascertainment drive variable expressivity of complex disorders

Matthew Jensen ∙ Corrine Smolen ∙ Anastasia Tyryshkina ∙ … ∙ Corrado Romano ∙ Joris Andrieux ∙ Santhosh Girirajan
Cell  Published:October 7, 2025
DOI:https://doi.org/10.1016/j.cell.2025.09.012

Highlights

  • Disease-associated variants show extensive phenotypic variability
  • The genetic background modifies the expressivity of neurodevelopmental phenotypes
  • Modifier effects are disease, population, and primary-variant specific
  • Ascertainment bias confounds genotype-phenotype studies

Summary

Variable expressivity of disease-associated variants implies a role for secondary variants that modify clinical features. We assessed the effects of modifier variants on the clinical outcomes of 2,455 individuals with primary variants. Among 124 families with the 16p12.1 deletion, distinct rare and common variant classes conferred risks for specific developmental features, including short tandem repeats for neurological defects. Network analysis suggested distinct mechanisms involving 16p12.1 genes and secondary variants specific to each proband. Within disease and population cohorts of 976 individuals with the 16p12.1 deletion, we found opposing effects of secondary variants on clinical features across ascertainments. Additional analysis of 1,479 probands with other primary variants, such as the 16p11.2 deletion and CHD8 variants, and 1,528 probands without primary variants showed that phenotypic associations differed by primary variant context and were influenced by synergistic interactions between primary and secondary variants. Our study provides a paradigm to dissect the personalized genomic architecture of complex disorders.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました